mRNA-1273 COVID-19 vaccine-induced Steven-Johnson syndrome
QJM
.
2023 Mar 27;116(3):247-249.
doi: 10.1093/qjmed/hcac282.
Authors
Hung-Kai Lo
1
,
Yu-Chieh Lin
2
,
Hung-Ming Chen
3
,
Po-Jen Hsiao
4
5
6
Affiliations
1
From the Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan.
2
Department of Pathology and Laboratory Medicne, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan.
3
Division of Hematology & Oncology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan.
4
Division of Nephrology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan.
5
Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
6
Department of Life Sciences, National Central University, Taoyuan, Taiwan.
PMID:
36592047
DOI:
10.1093/qjmed/hcac282
No abstract available
MeSH terms
2019-nCoV Vaccine mRNA-1273
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
Stevens-Johnson Syndrome*
Substances
2019-nCoV Vaccine mRNA-1273
COVID-19 Vaccines